Literature DB >> 1314369

Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related.

M Lilly1, T Le, P Holland, S L Hendrickson.   

Abstract

We have examined the effects of myeloid growth factors on expression of the pim-1 kinase protein in human and murine myeloid cells. pim-1 protein was identified in K562 cells by immunoblotting as a 33 kDa protein. In the human factor-dependent myeloid leukemia cell line M07E, pim-1 protein was induced by interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF), with maximum expression by 4 h. Expression continued for the duration of growth factor exposure, but declined rapidly when cytokines were removed. GM-CSF induced pim-1 protein in a dose-dependent manner, with expression being proportional to the proliferative effect of the cytokine. To examine the specificity of pim-1 protein induction, we compared pim-1 protein levels in myeloid cells which demonstrated different GM-CSF response phenotypes. We also examined the effects on pim-1 protein expression of different growth factors which induced similar response phenotypes. GM-CSF induced pim-1 protein in several myeloid cell lines, most of which demonstrated a proliferative response, but did not induce pim-1 protein expression in neutrophils or monocytic cells. In contrast, the murine cell line Mac-11 expressed pim-1 message in response to IL-3 and GM-CSF, but not in response to bryostatin or M-CSF, which were equivalent mitogens. In human U937 myeloid cells sustained expression of pim-1 protein was induced by GM-CSF, G-CSF and IL-6, but not by bryostatin. Expression of the pim-1 kinase protein in response to myeloid cytokines depends on both the nature of the growth factor and the response phenotype. The pim-1 kinase may be an important intermediate in transmembrane signaling or response phenotype induced by IL-3, GM-CSF and other cytokines whose receptors are structurally similar. Its constitutive expression in some myeloid leukemia cell lines suggests activation of signal cascades utilized by myeloid growth factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314369

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.

Authors:  Anissa M Jabbour; Carmel P Daunt; Benjamin D Green; Sandra Vogel; Lavinia Gordon; Rachel S Lee; Natasha Silke; Richard B Pearson; Cassandra J Vandenberg; Priscilla N Kelly; Stephen L Nutt; Andreas Strasser; Christoph Borner; Paul G Ekert
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

Review 3.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

4.  Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.

Authors:  Marina Y Zemskova; Jin H Song; Bo Cen; Javier Cerda-Infante; Viviana P Montecinos; Andrew S Kraft
Journal:  Cell Signal       Date:  2014-10-28       Impact factor: 4.315

5.  Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats.

Authors:  Kenichiro Yata; Gerald A Matchett; Tamiji Tsubokawa; Jiping Tang; Kenji Kanamaru; John H Zhang
Journal:  Brain Res       Date:  2007-02-17       Impact factor: 3.252

6.  Evidence that the Pim1 kinase gene is a direct target of HOXA9.

Authors:  Yu-Long Hu; Emmanuelle Passegué; Stephen Fong; Corey Largman; Hugh Jeffrey Lawrence
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

7.  Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation.

Authors:  Teija L T Aho; Riikka J Lund; Emmi K Ylikoski; Sampsa Matikainen; Riitta Lahesmaa; Päivi J Koskinen
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

8.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

9.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

Authors:  Marina Zemskova; Eva Sahakian; Svetlana Bashkirova; Michael Lilly
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.